Session Law

Identifying Information:L. 2002 ch. 025
Other Identifying Information:2002 Senate Bill 435
Tax Type:Other
Brief Description:An Act concerning livestock; relating to regulation of livestock remedies; amending K.S.A. 65-2701 and K.S.A. 2001 Supp. 65-679 and 65-1626; also repealing K.S.A. 47-501, 47- 502, 47-503, 47-505, 47-507, 47-508, 47-509, 47-510, 47-513, 47-514 and 47-515 and K.S.A. 2001 Supp. 47-504.
Keywords:


Body:

CHAPTER 25

SENATE BILL No. 435


An Act concerning livestock; relating to regulation of livestock remedies; amending K.S.A.

65-2701 and K.S.A. 2001 Supp. 65-679 and 65-1626; also repealing K.S.A. 47-501, 47-

502, 47-503, 47-505, 47-507, 47-508, 47-509, 47-510, 47-513, 47-514 and 47-515 and


K.S.A. 2001 Supp. 47-504.


Be it enacted by the Legislature of the State of Kansas:

Section 1. K.S.A. 2001 Supp. 65-679 is hereby amended to read as

follows: 65-679. Nothing in this act shall be construed as limiting or

abridging the authority of the secretary of agriculture established under

the Kansas dairy law, K.S.A. 2001 Supp. 65-771 through 65-791, and

amendments thereto; the Kansas livestock remedy law, K.S.A. 47-501

through 47-515, and amendments thereto; or the Kansas commercial

feeding stuffs law, K.S.A. 2-1001 through 2-1013, and amendments

thereto.

Sec. 2. K.S.A. 2001 Supp. 65-1626 is hereby amended to read as

follows: 65-1626. For the purposes of this act:

(a) ``Administer'' means the direct application of a drug, whether by

injection, inhalation, ingestion or any other means, to the body of a patient

or research subject by:

(1) A practitioner or pursuant to the lawful direction of a practitioner;

(2) the patient or research subject at the direction and in the presence

of the practitioner; or

(3) a pharmacist as authorized in K.S.A. 2001 Supp. 65-1635a and

amendments thereto.

(b) ``Agent'' means an authorized person who acts on behalf of or at

the direction of a manufacturer, distributor or dispenser but shall not

include a common or contract carrier, public warehouseman or employee

of the carrier or warehouseman when acting in the usual and lawful course

of the carrier's or warehouseman's business.

(c) ``Board'' means the state board of pharmacy created by K.S.A. 74-

1603 and amendments thereto.

(d) ``Brand exchange'' means the dispensing of a different drug prod-

uct of the same dosage form and strength and of the same generic name

than the brand name drug product prescribed.

(e) ``Brand name'' means the registered trademark name given to a

drug product by its manufacturer, labeler or distributor.

(f) ``Deliver'' or ``delivery'' means the actual, constructive or at-

tempted transfer from one person to another of any drug whether or not

an agency relationship exists.

(g) ``Direct supervision'' means the process by which the responsible

pharmacist shall observe and direct the activities of a pharmacy student

or pharmacy technician to a sufficient degree to assure that all such ac-

tivities are performed accurately, safely and without risk or harm to pa-

tients, and complete the final check before dispensing.

(h) ``Dispense'' means to deliver prescription medication to the ulti-

mate user or research subject by or pursuant to the lawful order of a

practitioner or pursuant to the prescription of a mid-level practitioner.

(i) ``Dispenser'' means a practitioner or pharmacist who dispenses

prescription medication.

(j) ``Distribute'' means to deliver, other than by administering or dis-

pensing, any drug.

(k) ``Distributor'' means a person who distributes a drug.

(l) ``Drug'' means: (1) Articles recognized in the official United States

pharmacopoeia, or other such official compendiums of the United States,

or official national formulary, or any supplement of any of them; (2) ar-

ticles intended for use in the diagnosis, cure, mitigation, treatment or

prevention of disease in man or other animals; (3) articles, other than

food, intended to affect the structure or any function of the body of man

or other animals; and (4) articles intended for use as a component of any

articles specified in clause (1), (2) or (3) of this subsection; but does not

include devices or their components, parts or accessories, except that the

term ``drug'' shall not include amygdalin (laetrile) or any livestock remedy,

as defined in K.S.A. 47-501 and amendments thereto, if such livestock

remedy has had been registered in accordance with the provisions of

article 5 of chapter 47 of the Kansas Statutes Annotated prior to its repeal.

(m) ``Electronic transmission'' means transmission of information in

electronic form or the transmission of the exact visual image of a docu-

ment by way of electronic equipment.

(n) ``Generic name'' means the established chemical name or official

name of a drug or drug product.

(o) (1) ``Institutional drug room'' means any location where prescrip-

tion-only drugs are stored and from which prescription-only drugs are

administered or dispensed and which is maintained or operated for the

purpose of providing the drug needs of:

(A) Inmates of a jail or correctional institution or facility;

(B) residents of a juvenile detention facility, as defined by the Kansas

code for care of children and the Kansas juvenile justice code;

(C) students of a public or private university or college, a community

college or any other institution of higher learning which is located in

Kansas;

(D) employees of a business or other employer; or

(E) persons receiving inpatient hospice services.

(2) ``Institutional drug room'' does not include:

(A) Any registered pharmacy;

(B) any office of a practitioner; or

(C) a location where no prescription-only drugs are dispensed and no

prescription-only drugs other than individual prescriptions are stored or

administered.

(p) ``Medical care facility'' shall have the meaning provided in K.S.A.

65-425 and amendments thereto, except that the term shall also include

facilities licensed under the provisions of K.S.A. 75-3307b and amend-

ments thereto except community mental health centers and facilities for

the mentally retarded.

(q) ``Manufacture'' means the production, preparation, propagation,

compounding, conversion or processing of a drug either directly or in-

directly by extraction from substances of natural origin, independently by

means of chemical synthesis or by a combination of extraction and chem-

ical synthesis and includes any packaging or repackaging of the drug or

labeling or relabeling of its container, except that this term shall not in-

clude the preparation or compounding of a drug by an individual for the

individual's own use or the preparation, compounding, packaging or la-

beling of a drug by: (1) A practitioner or a practitioner's authorized agent

incident to such practitioner's administering or dispensing of a drug in

the course of the practitioner's professional practice; (2) a practitioner,

by a practitioner's authorized agent or under a practitioner's supervision

for the purpose of, or as an incident to, research, teaching or chemical

analysis and not for sale; or (3) a pharmacist or the pharmacist's author-

ized agent acting under the direct supervision of the pharmacist for the

purpose of, or incident to, the dispensing of a drug by the pharmacist.

(r) ``Person'' means individual, corporation, government, govern-

mental subdivision or agency, partnership, association or any other legal

entity.

(s) ``Pharmacist'' means any natural person licensed under this act to

practice pharmacy.

(t) ``Pharmacist in charge'' means the pharmacist who is responsible

to the board for a registered establishment's compliance with the laws

and regulations of this state pertaining to the practice of pharmacy, man-

ufacturing of drugs and the distribution of drugs. The pharmacist in

charge shall supervise such establishment on a full-time or a part-time

basis and perform such other duties relating to supervision of a registered

establishment as may be prescribed by the board by rules and regulations.

Nothing in this definition shall relieve other pharmacists or persons from

their responsibility to comply with state and federal laws and regulations.

(u) ``Pharmacy,'' ``drug store'' or ``apothecary'' means premises, lab-

oratory, area or other place: (1) Where drugs are offered for sale where

the profession of pharmacy is practiced and where prescriptions are com-

pounded and dispensed; or (2) which has displayed upon it or within it

the words ``pharmacist,'' ``pharmaceutical chemist,'' ``pharmacy,'' ``apoth-

ecary,'' ``drugstore,'' ``druggist,'' ``drugs,'' ``drug sundries'' or any of these

words or combinations of these words or words of similar import either

in English or any sign containing any of these words; or (3) where the

characteristic symbols of pharmacy or the characteristic prescription sign

``Rx'' may be exhibited. As used in this subsection, premises refers only

to the portion of any building or structure leased, used or controlled by

the licensee in the conduct of the business registered by the board at the

address for which the registration was issued.

(v) ``Pharmacy student'' means an individual, registered with the

board of pharmacy, enrolled in an accredited school of pharmacy.

(w) ``Pharmacy technician'' means an individual who, under the direct

supervision and control of a pharmacist, may perform packaging, manip-

ulative, repetitive or other nondiscretionary tasks related to the processing

of a prescription or medication order and who assists the pharmacist in

the performance of pharmacy related duties, but who does not perform

duties restricted to a pharmacist.

(x) ``Practitioner'' means a person licensed to practice medicine and

surgery, dentist, podiatrist, veterinarian, optometrist licensed under the

optometry law as a therapeutic licensee or diagnostic and therapeutic

licensee, or scientific investigator or other person authorized by law to

use a prescription-only drug in teaching or chemical analysis or to conduct

research with respect to a prescription-only drug.

(y) ``Preceptor'' means a licensed pharmacist who possesses at least

two years' experience as a pharmacist and who supervises students ob-

taining the pharmaceutical experience required by law as a condition to

taking the examination for licensure as a pharmacist.

(z) ``Prescription'' means, according to the context, either a prescrip-

tion order or a prescription medication.

(aa) ``Prescription medication'' means any drug, including label and

container according to context, which is dispensed pursuant to a prescrip-

tion order.

(bb) ``Prescription-only drug'' means any drug whether intended for

use by man or animal, required by federal or state law (including 21

United States Code section 353, as amended) to be dispensed only pur-

suant to a written or oral prescription or order of a practitioner or is

restricted to use by practitioners only.

(cc) ``Prescription order'' means: (1) An order to be filled by a phar-

macist for prescription medication issued and signed by a practitioner or

a mid-level practitioner in the authorized course of professional practice;

or (2) an order transmitted to a pharmacist through word of mouth, note,

telephone or other means of communication directed by such practitioner

or mid-level practitioner.

(dd) ``Probation'' means the practice or operation under a temporary

license, registration or permit or a conditional license, registration or per-

mit of a business or profession for which a license, registration or permit

is granted by the board under the provisions of the pharmacy act of the

state of Kansas requiring certain actions to be accomplished or certain

actions not to occur before a regular license, registration or permit is

issued.

(ee) ``Professional incompetency'' means:

(1) One or more instances involving failure to adhere to the appli-

cable standard of pharmaceutical care to a degree which constitutes gross

negligence, as determined by the board;

(2) repeated instances involving failure to adhere to the applicable

standard of pharmaceutical care to a degree which constitutes ordinary

negligence, as determined by the board; or

(3) a pattern of pharmacy practice or other behavior which demon-

strates a manifest incapacity or incompetence to practice pharmacy.

(ff) ``Retail dealer'' means a person selling at retail nonprescription

drugs which are prepackaged, fully prepared by the manufacturer or dis-

tributor for use by the consumer and labeled in accordance with the

requirements of the state and federal food, drug and cosmetic acts. Such

nonprescription drugs shall not include: (1) A controlled substance; (2) a

prescription-only drug; or (3) a drug intended for human use by hypo-

dermic injection.

(gg) ``Secretary'' means the executive secretary of the board.

(hh) ``Unprofessional conduct'' means:

(1) Fraud in securing a registration or permit;

(2) intentional adulteration or mislabeling of any drug, medicine,

chemical or poison;

(3) causing any drug, medicine, chemical or poison to be adulterated

or mislabeled, knowing the same to be adulterated or mislabeled;

(4) intentionally falsifying or altering records or prescriptions;

(5) unlawful possession of drugs and unlawful diversion of drugs to

others;

(6) willful betrayal of confidential information under K.S.A. 65-1654

and amendments thereto;

(7) conduct likely to deceive, defraud or harm the public;

(8) making a false or misleading statement regarding the licensee's

professional practice or the efficacy or value of a drug;

(9) commission of any act of sexual abuse, misconduct or exploitation

related to the licensee's professional practice; or

(10) performing unnecessary tests, examinations or services which

have no legitimate pharmaceutical purpose.

(ii) ``Mid-level practitioner'' means an advanced registered nurse

practitioner issued a certificate of qualification pursuant to K.S.A. 65-1131

and amendments thereto who has authority to prescribe drugs pursuant

to a written protocol with a responsible physician under K.S.A. 65-1130

and amendments thereto or a physician assistant licensed pursuant to the

physician assistant licensure act who has authority to prescribe drugs pur-

suant to a written protocol with a responsible physician under K.S.A. 2001

Supp. 65-28a08 and amendments thereto.

(jj) ``Vaccination protocol'' means a written protocol, agreed to by a

pharmacist and a person licensed to practice medicine and surgery by the

state board of healing arts, which establishes procedures and recordkeep-

ing and reporting requirements for administering a vaccine by the phar-

macist for a period of time specified therein, not to exceed two years.

(kk) ``Veterinary medical teaching hospital pharmacy'' means any lo-

cation where prescription-only drugs are stored as part of an accredited

college of veterinary medicine and from which prescription-only drugs

are distributed for use in treatment of or administration to a non-human.

Sec. 3. K.S.A. 65-2701 is hereby amended to read as follows: 65-

2701. For the purposes of this act, the term ``hazardous household article''

shall mean means: Any article which purports to be useful in the accom-

plishment of any domestic task, any article for personal use, or any toy,

which is a substance or which contains substances that may be injurious

to human beings. This definition shall ``Hazardous household article'' does

not include the following: Foods, drugs or cosmetics as defined in K.S.A.

65-656, and any amendments thereto; agricultural chemicals as defined

in K.S.A. 2-2202, and any amendments thereto; livestock remedies as

defined in K.S.A. 47-501, and any amendments thereto prior to its repeal;

or state pharmacy act definitions included in K.S.A. 65-1626, or any and

amendments thereto.

Sec. 4. K.S.A. 47-501, 47-502, 47-503, 47-505, 47-507, 47-508, 47-

509, 47-510, 47-513, 47-514, 47-515 and 65-2701 and K.S.A. 2001 Supp.

47-504, 65-679 and 65-1626 are hereby repealed.

Sec. 5. This act shall take effect and be in force from and after its

publication in the statute book.

Approved April 4, 2002.


__________




Date Composed: 10/10/2002 Date Modified: 10/10/2002